Insiders · Profile

Atlas Venture Opportunity Fund II, L.P.

10% owner at Korro Bio · 10% owner at Dyne Therapeutics. Filing since 12 Dec 2022. CIK 0001885327

Company
Date
Role
Action
Shares
Amount
Of holding
22 Apr 2024
10% owner
Bought
17,857
$999.99K
10.1%
12 Dec 2022
10% owner
Bought
934,581
$10.00M
opened
2 decisions on file.